Cargando…

Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer’s Disease

[Image: see text] Alzheimer’s disease (AD) represents the most common cause of dementia worldwide and has been consistently associated with the loss of basal forebrain cholinergic neurons (BFCNs) leading to impaired cholinergic neurotransmission, aberrant synaptic function, and altered structural li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Llorente-Ovejero, Alberto, Martínez-Gardeazabal, Jonatan, Moreno-Rodríguez, Marta, Lombardero, Laura, González de San Román, Estíbaliz, Manuel, Iván, Giralt, María Teresa, Rodríguez-Puertas, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162383/ https://www.ncbi.nlm.nih.gov/pubmed/34037379 http://dx.doi.org/10.1021/acschemneuro.1c00169

Ejemplares similares

Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion
por: Llorente-Ovejero, Alberto, et al.
Publicado: (2022)

Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer’s Disease
por: González de San Román, Estibaliz, et al.
Publicado: (2021)

Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularis
por: Bengoetxea de Tena, Iker, et al.
Publicado: (2022)

CB(1) and LPA(1) Receptors Relationship in the Mouse Central Nervous System
por: González de San Román, Estíbaliz, et al.
Publicado: (2019)

Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer’s disease
por: Davis, Nicola, et al.
Publicado: (2021)

Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
por: Dwomoh, Louis, et al.
Publicado: (2022)

Convulsant bicuculline modifies CNS muscarinic receptor affinity
por: Schneider, Patricia G, et al.
Publicado: (2006)

Investigating the Unbinding of Muscarinic Antagonists from the Muscarinic 3 Receptor
por: Buigues, Pedro J., et al.
Publicado: (2023)

M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer’s disease pathology
por: Yi, Jee Hyun, et al.
Publicado: (2020)

Muscarinic receptor oligomerization
por: Marsango, Sara, et al.
Publicado: (2018)

Polymorphisms in the Cholinergic Receptors Muscarinic (CHRM2 and CHRM3) Genes and Alzheimer’s Disease
por: Chee, Lim Ya, et al.
Publicado: (2018)

Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
por: Wysocka, Adrianna, et al.
Publicado: (2020)

Changes in Phospholipid Composition of Erythrocyte Membrane in Alzheimer's Disease
por: Oma, Shinji, et al.
Publicado: (2012)

Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers
por: Kosicek, Marko, et al.
Publicado: (2013)

Phospholipid oxidation and carotenoid supplementation in Alzheimer’s disease patients
por: Ademowo, O.S., et al.
Publicado: (2017)

Striatal Input- and Rate-Dependent Effects of Muscarinic Receptors on Pallidal Firing
por: Querejeta, Enrique, et al.
Publicado: (2012)

Activation of M(1) and M(4) muscarinic receptors as potential treatments for Alzheimer’s disease and schizophrenia
por: Foster, Daniel J, et al.
Publicado: (2014)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

Muscarinic Receptors Associated with Cancer
por: Calaf, Gloria M., et al.
Publicado: (2022)

Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect
por: Ferreira, Inês, et al.
Publicado: (2022)

Muscarinic Receptors in Developmental Axonal Competition at the Neuromuscular Junction
por: Tomàs, Josep, et al.
Publicado: (2022)

Author Correction: Allergenicity to worldwide invasive grass Cortaderia selloana as environmental risk to public health
por: Rodríguez, Fernando, et al.
Publicado: (2022)

Allergenicity to worldwide invasive grass Cortaderia selloana as environmental risk to public health
por: Rodríguez, Fernando, et al.
Publicado: (2021)

Isolation and Analysis of Phospholipids in Dairy Foods
por: Pimentel, Lígia, et al.
Publicado: (2016)

Crosstalk between the M(1) muscarinic acetylcholine receptor and the endocannabinoid system: A relevance for Alzheimer's disease?
por: Thompson, Karen J., et al.
Publicado: (2020)

Loss of cholinergic receptor muscarinic 1 impairs cortical mitochondrial structure and function: implications in Alzheimer’s disease
por: Sabbir, Mohammad Golam, et al.
Publicado: (2023)

Allosteric Modulation of Muscarinic Acetylcholine Receptors
por: Gregory, Karen J, et al.
Publicado: (2007)

Allosteric Modulation of Muscarinic Acetylcholine Receptors
por: Jakubík, Jan, et al.
Publicado: (2010)

Muscarinic Receptor Signaling in Colon Cancer
por: von Rosenvinge, Erik C., et al.
Publicado: (2011)

Molecular properties of muscarinic acetylcholine receptors
por: HAGA, Tatsuya
Publicado: (2013)

Evolution of the Muscarinic Acetylcholine Receptors in Vertebrates
por: Pedersen, Julia E., et al.
Publicado: (2018)

Atropia, Duboisia, Eserine, Pilocarpine and Muscarine
por: Holmes, E. L.
Publicado: (1879)

Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
por: Kidambi, Neil, et al.
Publicado: (2023)

Neuroprotective and Antioxidant Role of Oxotremorine-M, a Non-selective Muscarinic Acetylcholine Receptors Agonist, in a Cellular Model of Alzheimer Disease
por: Nuzzo, Domenico, et al.
Publicado: (2022)

Molecular Conversion of Muscarinic Acetylcholine Receptor M(5) to Muscarinic Toxin 7 (MT7)-Binding Protein
por: Rondinelli, Sergio, et al.
Publicado: (2011)

Membrane-Derived Phospholipids Control Synaptic Neurotransmission and Plasticity
por: García-Morales, Victoria, et al.
Publicado: (2015)

Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer’s Disease
por: Volpato, Daniela, et al.
Publicado: (2018)

Phospholipids at the Interface: Current Trends and Challenges
por: Pichot, Roman, et al.
Publicado: (2013)

Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease
por: Bennett, Steffany A. L., et al.
Publicado: (2013)

Muscarinic and Nicotinic Modulation of Thalamo-Prefrontal Cortex Synaptic Pasticity In Vivo
por: Bueno-Junior, Lezio Soares, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c1j74pg05d84qmtn3ltsrrloo7